These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 14471252)

  • 1. D-Penicillamine as an antidote to 8-hydroxyquinoline and alloxan.
    MATSUDA M; MAKINO K
    Nature; 1961 Oct; 192():261-2. PubMed ID: 14471252
    [No Abstract]   [Full Text] [Related]  

  • 2. [THE USE OF PENICILLAMINE AND N-ACTYL-DL-PENICILLAMINE AS AN ANTIDOTE IN COPPER, LEAD AND MERCURY POISONINGS].
    VERVEEN G; ELSKAMP DM
    Pharm Weekbl; 1964 May; 99():547-54. PubMed ID: 14146274
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE USE OF PENICILLAMINE AND N-ACETYL-DL-PENICILLAMINE AS AN ANTIDOTE IN COPPER, LEAD AND MERCURY POISONINGS].
    VERVEEN G; ELSKAMP DM
    Pharm Weekbl; 1964 May; 99():577-8. PubMed ID: 14146276
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative evaluation and analysis of the bradykinin-potentiating properties of D-penicillamine and other thiol and non-thiol kininase inhibitors].
    Shvarts GIa
    Farmakol Toksikol; 1981; 44(3):327-30. PubMed ID: 6793390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism in vitro of the sulphydryl amino acids, L- and D-penicillamine.
    APOSHIAN HV; BRADHAM LS
    Biochem Pharmacol; 1959 Dec; 3():38-41. PubMed ID: 13793949
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel method for rapid copper chelation assessment confirmed low affinity of D-penicillamine for copper in comparison with trientine and 8-hydroxyquinolines.
    Říha M; Karlíčková J; Filipský T; Macáková K; Hrdina R; Mladěnka P
    J Inorg Biochem; 2013 Jun; 123():80-7. PubMed ID: 23563391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of D-penicillamine-cysteine mixed disulphide by reaction of D-benzylpenicilloic acid with cystine.
    LEVINE BB
    Nature; 1960 Sep; 187():940-1. PubMed ID: 13761467
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of D,L-penicillamine on the urinary excretion of copper and calcium in hepatolenticular degeneration (Wilson's disease).
    LITIN RB; GOLDSTEIN NP; RANDALL RV; POWER MH; DIESSNER GR
    Neurology; 1960 Feb; 10():123-6. PubMed ID: 14417516
    [No Abstract]   [Full Text] [Related]  

  • 9. Penicillamine: the pharmacology of a chelating agent.
    WALSHE JM
    Ann Intern Med; 1960 Nov; 53():1090-6. PubMed ID: 13782930
    [No Abstract]   [Full Text] [Related]  

  • 10. [On Wilson's disease. Also a contribution on penicillamine therapy].
    LANGE J; HAGER H
    Z Kinderheilkd; 1960; 84():125-36. PubMed ID: 13853564
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of Wilson's disease with penicillamine.
    WALSHE JM
    Lancet; 1960 Jan; 1(7117):188-92. PubMed ID: 13842679
    [No Abstract]   [Full Text] [Related]  

  • 12. Antidotes for gold (sodium bis[thiosulfato]gold[I]) intoxication in mice.
    Basinger MA; Gibbs SJ; Forti RL; Mitchell WM; Jones MM
    J Rheumatol; 1985 Apr; 12(2):274-8. PubMed ID: 2993607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penicillamine as lead-chelating substance in man.
    OHLSSON WT
    Br Med J; 1962 May; 1(5290):1454-6. PubMed ID: 14481385
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of Wilson's disease (hepatolenticular degeneration) with DL-penicillamine.
    GOLDSTEIN NP; RANDALL RV; GROSS JB; ROSEVEAR JW; McGUCKIN WF
    Neurology; 1962 Apr; 12():231-44. PubMed ID: 13899920
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of penicillamine as a diagnostic aid in hepatolenticular degeneration (Wilson's disease)].
    BLEHOVA B; HEYROVSKY L
    Cesk Pediatr; 1961 Sep; 16():809-11. PubMed ID: 13869965
    [No Abstract]   [Full Text] [Related]  

  • 16. Biochemical and pharmacological properties of the metal-binding agent penicillamine.
    APOSHIAN HV
    Fed Proc; 1961 Sep; 20(3)Pt 2():185-8. PubMed ID: 13861903
    [No Abstract]   [Full Text] [Related]  

  • 17. Colorimetric estimation of penicillamine.
    PAL PR
    J Biol Chem; 1959 Mar; 234(3):618-9. PubMed ID: 13641271
    [No Abstract]   [Full Text] [Related]  

  • 18. [Inhibition of enzymatic decarboxylation of amino acids by DL-penicillamine, L-cysteine and DL-homocysteine].
    MARDASHEV SR; SEMINA LA
    Biokhimiia; 1961; 26():31-9. PubMed ID: 13766612
    [No Abstract]   [Full Text] [Related]  

  • 19. The relative effectiveness of some chelating agents as antidotes in acute cadmium poisoning.
    Jones MM; Weaver AD; Weller WL
    Res Commun Chem Pathol Pharmacol; 1978 Dec; 22(3):581-8. PubMed ID: 216066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reversal of the inhibitory activity of L-penicillamine by branched chain amino acids.
    APOSHIAN HV; BLAIR RM; MORRIS M; SMITHSON CH
    Biochim Biophys Acta; 1959 Nov; 36():93-101. PubMed ID: 13793948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.